Reporte zur Charge UC8072AA

Symptomtext

fluzone high-dose qiv. administration of 2 doses instead of 1 with no reported adverse event; Initial information received on 14-Sep-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an unknown age and unknown gender patient who experienced Influenza Quadrival A-B High Dose HV Vaccine [Fluzone High-Dose Quadrivalent] administration of 2 doses instead of 1 with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 14-Sep-2023, the patient received 2 doses instead of 1 at dose 0.7 ml (Frequency = Twice) suspect Influenza Quadrival A-B High Dose HV Vaccine (lot: UC8072AA, Expiry date: 30-Jun-2024) with unknown formulation, strength via unknown route in unknown administration site for Immunization with no reported adverse event (overdose). Action taken: not applicable. At time of reporting, the outcome was Unknown.